SSRIs function by blocking the reuptake of serotonin in the synaptic cleft
Selective serotonin reuptake inhibitors (SSRIs) exert their pharmacological effects by blocking the reuptake of serotonin at the synapse, thereby increasing extracellular serotonin concentrations.
The claim describes the foundational, well-established pharmacological mechanism of SSRIs (Selective Serotonin Reuptake Inhibitors), which is consistently supported across the literature and foundational pharmacology.
Amber N. Edinoff, Haseeb A Akuly, T. Hanna, C. Ochoa, Shelby J Patti, Y. Ghaffar, Alan D Kaye, Omar Viswanath, Ivan Urits, Andrea G. Boyer, E. Cornett, A. Kaye. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. 2021. https://doi.org/10.3390/neurolint13030038
Paper 0 explicitly states that the primary mechanism of action of SSRIs is to inhibit the presynaptic reuptake of serotonin at the serotonin transporter, increasing synaptic serotonin levels.
See more details
Carolina Ruiz‑Santiago, Carla Rodríguez‑Pinacho, G. Pérez-Sánchez, Erika Acosta-Cruz. Effects of selective serotonin reuptake inhibitors on endocrine system (Review). 2024. https://doi.org/10.3892/br.2024.1816
Paper 3 confirms that SSRIs function by inhibiting serotonin reuptake, which raises serotonin levels in the synaptic cleft.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt